Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Nobel Laureate, Professor of Biology, Caltech
Managing Partner at Pappas Ventures
Managing Director, D.E. Shaw and Co., L.P.
|ReVision Planning Late-Stage Trial Next Year for Macular Degeneration Drug||Bruce V. Bigelow||10/18/10||San Diego|
|Otonomy Gets $38.5M, Avalon Helps Restart Drug for Age-Related Blindness, Accumetrics Heads Toward Profitability, & More San Diego Life Sciences News||Bruce V. Bigelow||09/02/10||San Diego|
|San Diego’s ReVision Therapeutics, Founded in April, Takes on Development of Drug Candidate for Age-Related Blindness||Bruce V. Bigelow||08/31/10||San Diego|
|Page 1 of 1|